KAON CL-10 Drug Patent Profile
When do Kaon Cl-10 patents expire, and what generic alternatives are available?
Kaon Cl-10 is a drug marketed by Savage Labs and is included in one NDA.
The generic ingredient in KAON CL-10 is potassium chloride. There is one drug master file entry for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kaon Cl-10
A generic version of KAON CL-10 was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KAON CL-10?
- What are the global sales for KAON CL-10?
- What is Average Wholesale Price for KAON CL-10?
Summary for KAON CL-10
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 250 |
| Patent Applications: | 3,661 |
| DailyMed Link: | KAON CL-10 at DailyMed |
US Patents and Regulatory Information for KAON CL-10
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savage Labs | KAON CL-10 | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 017046-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
